Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 23Neoplasm Metastasis 5Carcinoma, Renal Cell 5Recurrence 3Neoplasms 3Multiple Myeloma 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Leukemia 2Kidney Neoplasms 2Hematologic Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Sarcoma 1Peritoneal Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Lymphoma 1Liver Neoplasms 1Liver Cirrhosis 1Leukemia-Lymphoma, Adult T-Cell 1Hepatitis C, Chronic 1

Interventions

Ribavirin 4ledipasvir, sofosbuvir drug combination 2Chromatography, High Pressure Liquid 2tremelimumab 1telaprevir 1sofosbuvir-velpatasvir drug combination 1pembrolizumab 1peginterferon alfa-2a 1ledipasvir 1grazoprevir 1elbasvir-grazoprevir drug combination 1elbasvir 1Sofosbuvir 1Rapid Diagnostic Tests 1Patient Navigation 1Introns 1Infliximab 1Immunoenzyme Techniques 1Hypothermia, Induced 1Enzyme-Linked Immunosorbent Assay 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hepatitis C × Introns × Clear all
NCT00273247 2006-01-09

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

National Cancer Institute, Milan

Phase 3 Completed
150 enrolled
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡